Latest Whitepapers

Whitepaper
Accelerating Cancer Research Through Comprehensive Genomic Analysis
While next-generation sequencing is becoming increasingly routine in cancer research laboratories, it fails to address a number of key genomic drivers or markers of cancer, such as structural variations, DNA methylation and transcript isoforms.

Whitepaper
CRISPR Antibiotics: Turning Defense Into Offence
Download this whitepaper to discover how CRISPR can overcome antibiotic-resistant and pathogenic bacteria.

Whitepaper
Reagent Manufacturing for a Novel CRISPR-Based Diagnostic SARS CoV-2 Test
Download this whitepaper to discover how the manufacturing process was successfully scaled using operational support, a customized solution as well as a highly collaborative and strategic engagement.

Whitepaper
How CRISPR Can Help the Switch to Sustainable Cosmetics
The global cosmetics industry is worth more than $500 billion, but relies on ingredients that are unsustainable and cause harm to plant and animal life. Growing awareness of this problem among consumers has fueled a demand for something different.

Whitepaper
Streamline Antibody Labeling Workflows
Primary antibody labeling simplifies assays, enables multiplexing and eliminates the cross-reactivity seen with secondary antibodies – helping you to streamline your workflow, increase your flexibility and improve reproducibility.

Whitepaper
Improving Efficiency in Drug Discovery and Preclinical Development
Creating and bringing new drugs to the market can bring huge productivity challenges as the already complex drug development process becomes lengthier and more expensive.

Whitepaper
New for Old: The Value of Transitioning from qPCR to ddPCR
Droplet Digital PCR (ddPCR) is a refined form of digital PCR that offers a scalable and practical method for the absolute quantification of nucleic acids. 2021 marks ten years since the advent of ddPCR and in that time it has revolutionized discovery, development and quality control of biopharmaceuticals such as antibody-based biologics, vaccines, and cell and gene therapies.

Whitepaper
Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes
Download this whitepaper to uncover predicting disease onset via clinical biomarkers as well as other potential applications in diabetes research.

Whitepaper
Evolution in AAV Process Development: 2022 and Beyond
Over the last decade, the number of clinical trials involving recombinant adeno-associated viral (AAV) vectors has dramatically increased, the diversity of serotypes has expanded and the demand for larger quantities of highly purified material manufactured to cGMP standards has rocketed.

Whitepaper
Platform Optimization for Efficient AAV Purification
Download this whitepaper to discover how a contract development manufacturing organization was able to establish an AAV production platform and much more.
Advertisement